ArticleInternational journal of molecular medicine2020

miR‑135b‑5p enhances the sensitivity of HER‑2 positive breast cancer to trastuzumab via binding to cyclin D2.

Zhilan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.